Association of HLA—B8, DRw3, and Anti‐Acetylcholine Receptor Antibodies in Myasthenia Gravis
- 1 November 1978
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 12 (5) , 381-386
- https://doi.org/10.1111/j.1399-0039.1978.tb01347.x
Abstract
Twenty-eight patients with myasthenia gravis (MG), five with and 23 without thymoma, and 47 normal controls were typed for serologically defined HLA—A, B, C, and DRw antigens. Sera from all patients were titered for antibodies to acetylcholine receptors (AChR). The frequency of HLA—B8 and DRw3 in the non-thymoma MG patients was significantly higher than in the normal population. Most of the non-thymoma patients with AChR titers higher than the average level were positive for HLA—B8 and/or DRw3, while the majority of the HLA—B8 (—) and/or DRw3 (—) non-thymoma patients demonstrated AChR titers below average. These findings support the possibility of the existence of immune response genes in the HLA—B, DRw segment of the major histocompatibility complex which are concerned in the response to or recognition of autoantigens.This publication has 19 references indexed in Scilit:
- In Vitro Immune Responsiveness to Vaccinia Virus and HLANew England Journal of Medicine, 1977
- New Groups and Segregant Series Among B‐Cell Alloantigens of the Merrit System A Study of Leukemia Cells, Peripheral B Cells, and Lymphoblastoid Cell LinesScandinavian Journal of Immunology, 1977
- Sjögren's Syndrome Associated with HLA-Dw3New England Journal of Medicine, 1977
- An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravisClinical Immunology and Immunopathology, 1977
- HLA-UNKED GENETIC CONTROL OF HOST RESPONSE TO MYCOBACTERIUM LEPRÆThe Lancet, 1976
- HLA AND PANCREATIC ISLET CELL ANTIBODIES IN DIABETESThe Lancet, 1976
- HLA-DW3 ASSOCIATED WITH CŒLIAC DISEASEThe Lancet, 1976
- A New Alloantigenic System on Human LymphocytesTissue Antigens, 1975
- HL-A, IMMUNE-RESPONSE GENES, AND DISEASEPublished by Elsevier ,1974
- HL-A TYPES IN MYASTHENIA GRAVISThe Lancet, 1973